Navigation Links
The Beryl Institute Announces Call for Speakers for 2009 Conference Dedicated to Healthcare Customer Service: 'The Pursuit of Excellence'
Date:11/11/2008

DALLAS, Nov. 11 /PRNewswire/ -- The Beryl Institute is seeking speakers for its annual conference, March 31-April 3, 2009, in the Dallas/Ft. Worth Metroplex. The theme for the conference is "The Pursuit of Excellence." It is the premier conference dedicated to improving customer service in healthcare and will feature presentations, workshops and activities that provide actionable insight into ways healthcare organizations can deliver superior customer service.

The Beryl Institute has issued a call for speakers who can provide fresh, dynamic solutions to delivering exceptional customer service. "The Beryl Institute is looking to leverage customer service best practices from all business sectors, which can translate to healthcare," said Paul Spiegelman, executive director for The Beryl Institute. "The healthcare industry can learn from how other companies attract and retain customers for life."

Presentations may include keynotes, case studies, breakout sessions, interactive workshops and roundtable discussions. Speaker proposals will be accepted until December 31, 2008. More information about becoming a speaker at "The Pursuit of Excellence" is available at http://www.TheBerylInstitute.com/2009/callforspeakers.aspx.

Conference attendees receive early registration pricing before Jan. 15, 2009: $425 for the first attendee and $395 for subsequent attendees from the same organization. Additional information and registration is available at http://www.TheBerylInstitute.com/2009.

"The healthcare industry is really beginning to embrace customer service enhancements; and those that aren't, should," said Kristin Baird, past speaker at The Beryl Institute's conference and president of Baird Consulting. "This conference provides an excellent opportunity for healthcare organizations to learn how
'/>"/>

SOURCE The Beryl Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Modern Healthcare Names The Beryl Companies One of Best Places to Work in Healthcare
2. The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U.S.
3. The Beryl Companies Named to Inc. 5000 List for Second Consecutive Year
4. New White Paper from The Beryl Institute: Mystery Shopping the Patient Experience
5. Trinity Health System Selects Beryl as Preferred Provider to Enhance Telephone Customer Service
6. New VP of Operations Enhances The Beryl Companies Leadership Team
7. Beryl Expands Leadership Team, Adds Senior VP of Product Management and Marketing
8. The Beryl Companies Hires Nancy Lecroy as Vice President of Marketing Communications
9. The Beryl Companies Introduces New Customer Service Call Offering for Hospitals Nationwide
10. Free White Paper From The Beryl Institute Quantifies Bottom-Line Impact of Corporate Culture
11. Hurley Medical Center Enhances Customer Service Capabilities With Beryl Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...anies and three individuals have been recognized f...ional competition designed to reward workplace hea...yXChange.org community released its 2009 Saxcies g...w.safetyxchange.org/saxcies-video . The winners an...e their lives to keeping others safe - are detaile...
(Date:7/3/2009)...is is an opportunity for you to change your life -...ills, you will experience a noticeable relief from...r, cholesterol levels and blood pressure will retu...ur mind will finally be freed from the health conc...." , Miami, FL (PRWE...
(Date:7/3/2009)...HomeCare, a home medical services provider special...ry and DME services, is expanding. Two new pharmac...in home infusion therapy and one in oral medicatio... Clinton, NY (PRWEB) June 22, ...s provider specializing in infusion, specialty med...
(Date:7/2/2009)...cessing Technology Institute (BTI) have made a nov...hibitory molecule" (FAIM), protects both immune an...eath. , Their research is published in the curr...The scientists, Jianxin Huo, Ph.D., and Shengli Xu...sibly be manipulated for clinical application and ...
Breaking Medicine News(10 mins):Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2
...ch conducted by French doctors has revealed that t...s and insecticides run a higher chance of contract...ronmental Medicine journal //has published this re...exposing children to mosquito repellents also. Th...
...have a history of heart problems and consume anti-...f getting their eyesight damaged, according to a s... researchers suggest that taking viagra may result...lood flow, giving rise to tissue damage. The Briti...
...ram Ayurvedic Hospital and Beach Resort, located c...alth care packages for treatment of what is called...tunnel syndrome (CTS). //The unique health care s... Somatheeram chief Poly Mathew said Monday: "The...
...s, World Bank Vice-president has urged the world r...s conference which took place in Beijing to provid...n increased need of funds required by economically...flu. World Bank estimates that more than $ 1.5 bil...
Other Medicine News:
(Date:6/29/2009)...minal surgery patients achieved primary and second... AcelRx Pharmaceuticals, Inc. toda... 2 clinical study evaluating the safety and effica...anagement of acute post-operative pain in patients.... Compared to placebo, patients receiving ARX-01 S...
(Date:6/28/2009)...RONADO, Portugal, June 29 Data pre...on treatment with the novel,once-daily anti-epil...esulted,in a marked and sustained decrease in sei...ults from the one-year extension of a pivotal Esli...d at the International Congress for Epilepsy in,B...
(Date:6/26/2009)...ease, "Agendia,s Breast Cancer Recurrence Test Mam...rt Consensus Recommendations" issued,on 23 Jun 20...ease be advised,that the subheadline was missing ... Newswire. Complete, corrected release follows: ,...ast Cancer Recurrence Test MammaPrint Included in,...
(Date:6/25/2009)...PRNewswire-USNewswire/ -- As of mid-2009, The Mich... already funded over $1 million in high-risk, high...lopment through its groundbreaking Rapid Response...ns of the safety and efficacy of an FDA-approved d...cterization of a tenuous link between PD and certa...
Breaking Medicine Technology:AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3Vasogen Complies with NASDAQ Marketplace Rule 4350 28c 29 281 29 10027 1Vasogen Complies with NASDAQ Marketplace Rule 4350 28c 29 281 29 10027 2Orthopaedic Surgeon Kevin Smith MD Joins Northwest Hospital 26 Medical Center and The Sports Medicine Clinic 34320 1Orthopaedic Surgeon Kevin Smith MD Joins Northwest Hospital 26 Medical Center and The Sports Medicine Clinic 34320 2Older Drug Effective in Treating Pediatric Nerve Cancer 34318 1Older Drug Effective in Treating Pediatric Nerve Cancer 34318 2Why Saying No to Foods May Be Harder for Women 34316 1Why Saying No to Foods May Be Harder for Women 34316 2
...Jul 9, 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIO...going phase II trial of ZIO-201 (isophosphoramide ...was presented at the,European Society of Medical O...no, Switzerland. The abstract entitled, "Phase-I/I... presented by,Rashmi Chugh, MD, a Principal Invest...
... Late-breaking Phase III,clinical trial data prese...ombosis and Haemostasis (ISTH) Congress demonstrat...ficacy in the,prevention of venous thromboembolism...gery in a head-to-head comparison with,enoxaparin,...ORD3,(REgulation of Coagulation in major Orthopaed...
Other Medicine Technology:Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
Nitinol Flat Wire Basket
The Reichert MK1 Keratometer now utilizes LED technology to provide clear, consistent lighting, removing the need to ever change bulbs. What we didnt change are all the great features that have made
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology.
For presumptive identification of E. coli serogroup O157:H7 cultured on laboratory media.
Medicine Products: